Proton inobudirira kubata varwere vevana vane rhabdomyosarcoma

Share This Post

In September 2015, a child patient with rhabdomyosarcoma in Guangdong, China successfully completed proton radiotherapy at the Proton Center of the Eastern Hospital of the National Cancer Center in Japan.

The family members of the children took photos with the doctors and nurses of proton radiotherapy to celebrate the successful completion of the treatment. When the little patient was seen on November 23, 2014, he had already experienced abdominal pain for half a month, and had a fever for four days. . The results of the biopsy on November 27 were considered embryonic rhabdomyosarcoma. Stage 4 chemotherapy was performed from December 1, 2014 to February 4, 2015, and surgery was performed on April 10, 2015. Postoperative pathological diagnosis was biased towards embryonic rhabdomyosarcoma.

Nhengo dzemhuri dzevana vakatora foto yeboka naDr Akio Akimoto, mukuru weProton Center yeNational Cancer Center yeJapan.

 Ivo baba vemurwere vakakurumidza kubata XKmed (naKang Evergreen), vakafonera Mai Bi Yanan vanobva kuInternational Medical department, vakabvunza nezverwendo rwekuJapan uye vakaita kubvunza kwekure. kurapwa.

Zvakatora unenge mwedzi mumwe kubva pakutanga kwekutaurirana kusvika pakutanga kwekurapa muJapan, kusanganisira kunyorera vhiza. Nhengo dzemhuri dzevarwere dzakatora masiraidhi avo eChina uye vakaita chirwere chekuongorora zvekare kuNational Cancer Center. Mhedzisiro yacho yaionekwawo kunge embryonic rhabdomyosarcoma kusvika padanho rakakura.

Uyu murwere mudiki nemhuri yake, vakawana vhiza yekurapa musi waJune 24, 2015, vakasvika muJapan musi wa28 Chikumi, vakatanga kuongorora musi waJune 29, uye vakapedza kuongorora muna Chikunguru 1. Muzvinafundo Qiu Yuan, mutevedzeri wemukuru weEastern Hospital. weNational Cancer Center yeJapan, akaita chirongwa chekurapa. Nguva yekurapwa iri kubva muna Chikunguru 14 kusvika Nyamavhuvhu 18, 2015. Iyo yakazara dose ndeye: 41.4GyE, huwandu hwakazara hwe23.

On August 20, 2015, the patient’s family boarded a flight back home and successfully completed proton therapy. According to the final treatment report of the National Cancer Center, the CD of the CT before and after the patient’s irradiation has also been passed to the father of the patient.

National Cancer Center ndiyo inzvimbo yekurapa gomarara zvakanyanya muJapan, uye inozivikanwawo pasi rese. National Cancer Center East Hospital yakavambwa muChiba Prefecture muna 1992. Proton therapy ndiyo imwe yezvinhu zviri pano, uye yave nemukurumbira nekuda kwekuporeswa kwevakakurumbira mutsika dzechiJapan. Iyo proton Therapy system pano ndiyo yekutanga muJapan uye yechipiri institution yezvekurapa munyika kutanga kiriniki kunyorera

Dr. Akio Akimoto, mutevedzeri wemutungamiriri weEastern Hospital yeNational Cancer Center uye mukuru weiyo radiotherapy uye proton nzvimbo muJapan, ane ruzivo rwakakura rwekurapa semusoro. Nekuunza Kang Evergreen kubatsira varwere vanorapwa muJapan, vanogona kuwana mukana wekuzvirapa naDr. Akimoto. Vazhinji varwere vekenza veJapan zvakare vashoma.

Rhabdomyosarcoma (RMS) ibundu rakaipa remukati mekutanga. Iyo ndiyo yakajairika mhando yeiyo yakapfava tishu sarcoma muvana. Kuitika kwaro kwakaderera kune yakaipa malibrous histiocytoma uye liposarcoma.

Kunyangwe mutengo wekushandisa kurapa kweproton kwevarwere vevana wakakwira kupfuura weiyo photon Therapiki, kana iyo yekurapa mutengo wekurapa kunonoka kuita kwakashata uchifungidzirwa mune idzi ongororo, proton kurapa pakupedzisira inozoponesa iyo yakazara yekurapa mutengo nekuti proton Therapisi inoderedza kunonoka kusagadzikana kuita mushure mekurapa.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Basa revaparamedics mukubudirira kweCAR T Cell therapy
CAR T-Cell kurapa

Basa revaparamedics mukubudirira kweCAR T Cell therapy

Paramedics inobata basa rakakosha mukubudirira kweCAR T-cell therapy nekuona kuchengetwa kwemurwere pasina musono panguva yese yekurapa. Vanopa rubatsiro rwakakosha panguva yekufambisa, kutarisa zviratidzo zvinokosha zvevarwere, uye kupa rubatsiro rwechimbichimbi kana matambudziko amuka. Kupindura kwavo nekukurumidza uye kutarisirwa kwehunyanzvi kunobatsira mukuchengetedzeka kwese uye kushanda kwekurapa, kufambisa shanduko yakapfava pakati pezvirongwa zvehutano uye kuvandudza mhedzisiro yevarwere munzvimbo yakaoma yemhando yepamusoro cellular therapies.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa